RESUMO
This study compared neurological complications among a national sample of United States children with or without sickle cell disease (SCD) and evaluated health status, healthcare and special education utilization patterns, barriers to care, and association of SCD status and demographics/socioeconomic status (SES) on comorbidities and healthcare utilization. Data was acquired from the National Health Interview Survey (NHIS) Sample Child Core questionnaire 2007-2018 dataset that included 133,542 children. An affirmation from the guardian of the child determined the presence of SCD. Regression analysis was used to compare the associations between SCD and demographics/SES on neurological conditions at p < 0.05. Furthermore, adjusted odds ratios (AORs) were estimated for having various neurological conditions. Of the 133,481 children included in the NHIS, the mean age was 8.5 years (SD: 0.02) and 215 had SCD. Of the children with SCD, the sample composition included male (n = 110), and Black (n = 82%). The SCD sample had higher odds of having neuro-developmental conditions (p < 0.1). Families of Black children (55% weighted) reported household incomes < 100% of federal poverty level. Black children were more likely to experience longer wait times to see the doctor (AOR, 0.3; CI 0.1-1.1). Compared to children without SCD, those with SCD had a greater chance of seeing a medical specialist within 12 months (AOR 2.3; CI 1.5-3.7). This representative sample of US children with SCD shows higher odds of developing neurological complications, increased healthcare and special education services utilization, with Black children experiencing a disproportionate burden. This creates the urgency to address the health burden for children with SCD by implementing interventions in healthcare and increasing education assistance programs to combat neurocognitive impairments, especially among Black children.
Assuntos
Anemia Falciforme , Doenças do Sistema Nervoso , Criança , Humanos , Masculino , Anemia Falciforme/complicações , Anemia Falciforme/epidemiologia , Anemia Falciforme/etnologia , População Negra/estatística & dados numéricos , Atenção à Saúde , Nível de Saúde , Doenças do Sistema Nervoso/epidemiologia , Doenças do Sistema Nervoso/etiologia , Inquéritos e Questionários , Estados Unidos/epidemiologia , Utilização de Instalações e Serviços/estatística & dados numéricos , Acessibilidade aos Serviços de Saúde , Determinantes Sociais da Saúde/etnologia , Determinantes Sociais da Saúde/estatística & dados numéricos , Feminino , Efeitos Psicossociais da Doença , Transtornos Neurocognitivos/epidemiologia , Transtornos Neurocognitivos/etnologia , Transtornos Neurocognitivos/etiologiaRESUMO
Importance: Adults with sickle cell disease (SCD) disproportionally experience early cognitive decline; however, guidance on the optimal screening strategy for cognitive dysfunction is lacking, and several available tools are biased by language, educational level, socioeconomic status, and race/ethnicity. The Rowland Universal Dementia Assessment Scale (RUDAS) was specifically designed for cognitive screening in multicultural populations. Objective: To ascertain the prevalence of suspected dementia in adults with SCD using the RUDAS, and to identify whether age, sex, educational level, several biological variables, and SCD complications were associated with RUDAS scores. Design, Setting, and Participants: This multicenter, bilingual, cross-sectional study was conducted in 2 SCD comprehensive care centers in Canada (Centre Hospitalier de l'Université Montréal in Montréal and University Health Network in Toronto). Participants were adults aged 18 years or older and were enrolled in the study between July 1, 2018, and July 30, 2019. All outpatients were eligible and offered study participation, unless they had an acute medical condition that required inpatient care or they were unable to follow study instructions. Interventions: The RUDAS was administered by trained personnel in either French or English, according to the patient's language preference. A questionnaire on social determinants of health was also administered, and participants underwent screening for anxiety and depression. Main Outcomes and Measures: Proportion of participants with RUDAS scores that were suggestive of dementia and the RUDAS score. Any score lower than 23 points was suggestive of dementia, a score between 23 and 27 points indicated a possible association with mild neurocognitive disorder, and a score higher than 27 points was normal. Results: A total of 252 adult patients with SCD were included (136 women [54.0%]; mean [range] age, 34.8 [18-75] years). Overall, 29 patients (11.5%) had RUDAS scores that were suggestive of dementia, and this proportion increased with age (15 [8.7%] in the 18-39 years age group, 10 [14.5%] in the 40-59 years age group, and 4 [36.4%] in the ≥60 years age group). The RUDAS scores were not associated with sex, language, SCD genotype, and SCD complications. The highest level of education was significantly associated with the RUDAS score; however, the association was small (η2 = 0.02; 95% CI, 0.00-0.07; P = .02). In a multivariable analysis, lower glomerular filtration rate (r = 0.40; 95% CI, 0.29-0.50; P < .001) and increasing age (r = -0.37; 95% CI, -0.47 to -0.26; P < .001), but not SCD genotype or disease severity, were associated with lower RUDAS scores. Conclusions and Relevance: This study found that using the RUDAS revealed a high prevalence of suspected dementia in adult patients with SCD that was associated with worsening kidney function and age. Cognition should be screened in all adult patients with SCD, regardless of age, disease severity, and SCD genotype; further validation of the RUDAS is ongoing.
Assuntos
Anemia Falciforme/psicologia , Disfunção Cognitiva/diagnóstico , Demência/diagnóstico , Testes de Estado Mental e Demência , Adolescente , Adulto , Fatores Etários , Idoso , Anemia Falciforme/etnologia , Canadá/epidemiologia , Disfunção Cognitiva/epidemiologia , Estudos Transversais , Diversidade Cultural , Demência/epidemiologia , Escolaridade , Feminino , Taxa de Filtração Glomerular , Humanos , Rim/fisiopatologia , Masculino , Pessoa de Meia-Idade , Adulto JovemRESUMO
Our health care system in the United States reflects the inequities that are part of the larger society, which is why our system for financing access to needed and effective health care is so complicated and unfair.
Assuntos
Anemia Falciforme/etnologia , Negro ou Afro-Americano , Acessibilidade aos Serviços de Saúde/organização & administração , Disparidades nos Níveis de Saúde , Anemia Falciforme/economia , COVID-19/etnologia , Acessibilidade aos Serviços de Saúde/economia , Hispânico ou Latino , Humanos , Cobertura do Seguro/estatística & dados numéricos , Seguro Saúde/estatística & dados numéricos , SARS-CoV-2 , Estados UnidosRESUMO
Sickle cell disease (SCD) is an inherited blood disorder most common among African American and Hispanic American persons. The disease can cause substantial, long-term, and costly health problems, including infections, stroke, and kidney failure, many of which can reduce life expectancy. Disparities in receiving health care among African Americans and other racial/ethnic minority groups in the United States are well known and directly related to poor outcomes associated with SCD. As an orphan disease-one that affects <200 000 persons nationwide-SCD does not receive the research funding and pharmaceutical investment directed to other orphan diseases. For example, cystic fibrosis affects fewer than half the number of persons but receives 3.5 times the funding from the National Institutes of Health and 440 times the funding from national foundations. In this review, we discuss the health inequities affecting persons with SCD, describe programs intended to improve their care, and identify actions that could be taken to further reduce these inequities, improve care, control treatment costs, and ease the burden of disease.
Assuntos
Anemia Falciforme/complicações , Anemia Falciforme/terapia , Negro ou Afro-Americano/estatística & dados numéricos , Acessibilidade aos Serviços de Saúde , Disparidades em Assistência à Saúde/etnologia , Hispânico ou Latino/estatística & dados numéricos , Anemia Falciforme/etnologia , Custos de Cuidados de Saúde , Humanos , Cobertura do Seguro/estatística & dados numéricos , Estados UnidosRESUMO
In 2006, the committee that developed the National Health Policy for the Black Population (NHPBP) chose sickle cell disease as their "flag to demand health rights." The drafting of this policy was official recognition from the Ministry of Health for racial differences of its citizens in order to address certain inequalities in the form of racial health reparations. Through an ethnographic study which consisted of participant observation, life-story and semi-structured interviews, and surveys in the urban centers of Rio de Janeiro, São Paulo, Salvador, Belo Horizonte, and Brasília between November 2013 and November 2014, I introduce a new conceptual approach called biocultural citizenship. It is a flexible mode of enacting belonging that varies depending on disease status, skin color, social class, recognition of African lineage, and other identifiers. Using empirical evidence, this article explores how people living with sickle cell disease (SCD), civil society, and the Brazilian government-at state and federal levels-have contributed to the discourse on SCD as a "black" disease, despite a prevailing cultural ideology of racial mixture. Specifically, I demonstrate that the SCD movement strategically uses Blackness to make claims for health rights. Biocultural citizenship is dependent on the idea of biological and cultural difference that is coproduced by the State and Afro-Brazilian citizens. The use of biology to help legitimate cultural claims, especially in the Black Atlantic, contributes a new and distinct way to think about how race and skin color are used as tools of agency for diasporic communities.
Assuntos
Anemia Falciforme/etnologia , Disparidades nos Níveis de Saúde , Grupos Raciais/estatística & dados numéricos , Adolescente , Adulto , Biologia , Brasil , Características Culturais , Feminino , Política de Saúde , Humanos , Masculino , Pessoa de Meia-Idade , Política , Adulto JovemRESUMO
Sickle cell disease is an inherited hemoglobinopathy associated with significant morbidity and mortality. Reports suggest a high sickle cell disease burden among the indigenous Tharu population of Nepal, who for centuries have inhabited regions where malaria is endemic. Unfortunately, health care resources are limited and often inaccessible for Tharu individuals suffering from sickle cell disease. We conducted a large-scale screening effort to estimate the prevalence of Hb S (HBB: c.20A>T) among the Tharu population and delivered community-based education sessions to increase sickle cell disease awareness. A total of 2899 Tharu individuals aged 6 months to 40 years in the rural district of Dang in Western Nepal were screened using a sickling test, of whom, 271 [9.3%; 95% confidence interval (95% CI): 8.3-10.4%] screened positive for Hb S. Those who screened positive were offered diagnostic gel electrophoresis testing. Of the 133 individuals who underwent diagnostic testing, 75.9% (n = 101) were confirmed to be Hb AS heterozygotes, 4.5% (n = 6) were confirmed to be Hb SS homozygotes and 19.5% (n = 26) were false positives. These findings support a large burden of sickle cell disease among the Tharu population and highlight the importance of appropriate resource allocation and management. With a positive predictive value of 80.0% (95% CI: 73.0-87.0%), the sickling test in conjunction with raising local sickle cell disease awareness may be a simple and sustainable way to promote access to health resources.
Assuntos
Anemia Falciforme , Hemoglobina Falciforme/genética , Homozigoto , Anemia Falciforme/epidemiologia , Anemia Falciforme/etnologia , Anemia Falciforme/genética , Feminino , Humanos , Masculino , Nepal/epidemiologia , Nepal/etnologia , PrevalênciaRESUMO
BACKGROUND: Hemoglobinopathies are associated with significant morbidity and mortality. Accurate epidemiologic data reflecting the number of hemoglobinopathy patients are lacking in Canada. Immigration patterns are shifting such that regions where these diseases were rare are seeing a rapid population expansion, revealing a gap in the health care system and the need for a public health response. METHODS: To understand the epidemiology of pediatric hemoglobinopathy patients given the provincial population growth and immigration patterns, a retrospective chart review was conducted at the Stollery Children's Hospital from January 2004 to July 2014. RESULTS: A total of 88% of patients had sickle cell disease; 55% of patients were Canadian born and 63% of families originated from Africa. There was a 3.5-fold increase in patient numbers with acceleration in patient accrual over the study period and a delay in diagnosis in 70% of patients. There was a significant increase in the number of hospitalizations over the study period. Thirteen percent required at least 1 exchange transfusion, 16% received chronic transfusions, and 30% of patients developed at least 1 severe complication related to their diagnosis. CONCLUSIONS: It is imperative to demonstrate the growing hemoglobinopathy population and changing health care requirements to advocate for appropriate resources, educate health care providers, and increase awareness.
Assuntos
Anemia Falciforme/epidemiologia , Talassemia/epidemiologia , Síndrome Torácica Aguda/epidemiologia , Síndrome Torácica Aguda/etiologia , Adolescente , África/etnologia , Alberta/epidemiologia , Anemia Falciforme/complicações , Anemia Falciforme/etnologia , Anemia Falciforme/terapia , Ásia/etnologia , Transfusão de Sangue/estatística & dados numéricos , Região do Caribe/etnologia , Criança , Pré-Escolar , Emigrantes e Imigrantes/estatística & dados numéricos , Feminino , Deficiência de Glucosefosfato Desidrogenase/epidemiologia , Deficiência de Glucosefosfato Desidrogenase/etnologia , Recursos em Saúde/provisão & distribuição , Recursos em Saúde/tendências , Necessidades e Demandas de Serviços de Saúde , Hematologia/organização & administração , Hospitalização/estatística & dados numéricos , Hospitais Pediátricos/estatística & dados numéricos , Humanos , Lactente , Recém-Nascido , Sobrecarga de Ferro/epidemiologia , Sobrecarga de Ferro/etiologia , Masculino , Morbidade/tendências , Ambulatório Hospitalar/estatística & dados numéricos , Estudos Retrospectivos , Acidente Vascular Cerebral/epidemiologia , Acidente Vascular Cerebral/etiologia , Talassemia/complicações , Talassemia/etnologia , Talassemia/terapia , Reação TransfusionalRESUMO
Sickle Cell Disease (SCD) is a burdensome and prevalent condition predominantly seen in populations of African heritage. Treatments for SCD, particularly those related to pain crisis, are largely insufficient. We argue that it is through structural violence-a systemic series of policies, institutions, and practices-that individuals who live with SCD suffer from health disparities. Similarly, we argue against other suggested mechanisms and causes, such as purely economic factors or low public interest and knowledge. We shall do this in part by comparing the systemic response to SCD to that of Cystic Fibrosis (CF), another genetic based illness with similar prevalence. Notably, CF that affects a very different target population, and has very different research, funding, and treatment trajectories. Underlying these arguments is the hypothesis that structural violence can harm a population in a developed nation just as it can in a developing one.
Assuntos
Anemia Falciforme/etnologia , Negro ou Afro-Americano , Disparidades em Assistência à Saúde/etnologia , Violência , Anemia Falciforme/terapia , Pesquisa Biomédica , Criança , Fibrose Cística/epidemiologia , Fibrose Cística/terapia , Humanos , Apoio à Pesquisa como Assunto , Estados Unidos/epidemiologiaRESUMO
Despite major public health initiatives, significant disparities persist among racially and ethnically defined groups in the prevalence of disease, access to medical care, quality of medical care, and health outcomes for common causes of morbidity and mortality in the United States. It is critical that we develop new and creative strategies to address such inequities; mitigate the social, environmental, institutional, and genetic determinants of poor health; and combat the persistence of racial profiling in clinical contexts that further exacerbates racial/ethnic health disparities. This article argues that medical education is a prime target for intervention and that anthropologists and human population geneticists should play a role in efforts to reform US medical curricula. Medical education would benefit greatly by incorporating anthropological and genetic perspectives on the complexities of race, human genetic variation, epigenetics, and the causes of racial/ethnic disparities. Medical students and practicing physicians should also receive training on how to use this knowledge to improve clinical practice, diagnosis, and treatment for racially diverse populations.
Assuntos
Dor Abdominal/etnologia , Anemia Falciforme/etnologia , Educação Médica/organização & administração , Variação Genética/genética , Disparidades nos Níveis de Saúde , Disparidades em Assistência à Saúde/etnologia , Dor Abdominal/diagnóstico , Dor Abdominal/etiologia , Anemia Falciforme/diagnóstico , Antropologia , Criança , Currículo , Doença/etnologia , Epigenômica , Etnicidade , Humanos , Masculino , Morbidade , Mortalidade/etnologia , Grupos Raciais , Segregação Social , Estados Unidos/epidemiologia , Estados Unidos/etnologia , Adulto JovemRESUMO
This qualitative study focused on the experiences of adults living with sickle cell disease (SCD) in the New York City area. Twenty-three individuals participated in one of three focus groups. The purpose of this study was to learn if appropriate health care for individuals with sickle cell disease, based on years of research, has been implemented. The findings indicate that best practices in the treatment of SCD are often not followed by medical personnel. Critical race theory provides a framework to understand the 10 emergent themes. The participants' responses illustrate resilience in facing adversity. Implications for social work practice are presented.
Assuntos
Anemia Falciforme/psicologia , Anemia Falciforme/terapia , Resiliência Psicológica , Adolescente , Adulto , Idoso , Anemia Falciforme/etnologia , Feminino , Grupos Focais , Acessibilidade aos Serviços de Saúde , Necessidades e Demandas de Serviços de Saúde , Humanos , Masculino , Pessoa de Meia-Idade , Cidade de Nova Iorque , Pesquisa QualitativaRESUMO
BACKGROUND: Although obstetrician/gynecologists (OB/GYNs) play an important role in sickle cell disease (SCD) screening and patient care, there is little information on knowledge of SCD or sickle cell trait (SCT) or related practices in this provider group. Our objective was to assess SCD screening and prenatal management practices among OB/GYNs. METHODS: Twelve hundred Fellows and Junior Fellows of the American College of Obstetricians and Gynecologists (the College)a were invited to complete a mailed survey, of which half (n = 600) belonged to the Collaborative Ambulatory Research Network.b Participants answered questions regarding appropriate target patient groups for prenatal SCD screening, folic acid requirements, practice behaviors and adequacy of their medical school and residency training. RESULTS: A total of 338 CARN members (56.3%) and 165 non-CARN members (27.5%) returned a survey. Of the 503 responders, 382 provided obstetric services and were included in the analyses. Forty percent of these respondents (n = 153) reported seeing at least 1 patient with SCD in the last year. Of these, 97.4% reported regularly screening people of African descent for SCD or SCT, whereas 52.9% reported regularly screening people of Mediterranean descent and 30.1% reported regularly screening people of Asian descent. Only 56.2% knew the correct recommended daily dose of folic acid for pregnant women with SCD. The proportion of respondents that rated training on SCD screening, assessment and treatment as barely adequate or inadequate ranged from 19.7% to 39.3%. CONCLUSIONS: The practice of many OB/GYNs who care for patients with SCD are not consistent with the College Practice Guidelines on the screening of certain target groups and on folic acid supplementation. There may be an opportunity to improve this knowledge gap through enhanced medical education.
Assuntos
Anemia Falciforme/diagnóstico , Competência Clínica , Ginecologia , Obstetrícia , Complicações Hematológicas na Gravidez/diagnóstico , África/etnologia , Anemia Falciforme/tratamento farmacológico , Anemia Falciforme/etnologia , Ásia/etnologia , Educação Médica/normas , Bolsas de Estudo , Feminino , Ácido Fólico/uso terapêutico , Ginecologia/educação , Humanos , Masculino , Programas de Rastreamento , Região do Mediterrâneo/etnologia , Pessoa de Meia-Idade , Obstetrícia/educação , Gravidez , Complicações Hematológicas na Gravidez/tratamento farmacológico , Complicações Hematológicas na Gravidez/etnologia , Traço Falciforme/diagnóstico , Traço Falciforme/etnologia , Complexo Vitamínico B/uso terapêuticoRESUMO
Besides specific organisational requirements, the transfusional chain in French ultra-marine areas has specificities related to the epidemiology of infectious diseases and to population characteristics. We focus on some of these sociodemographic and medical peculiarities: the challenge of autosufficiency in relation to demographic trends; epidemiologic risks associated to emergent viruses such as dengue and Chikungunya, and the strategies that had been implemented to face last outbreaks; inappropriate selection criteria for eligibility to blood donation (biologic characteristics of Afro-Caribbeans not taken into account for the low hemoglobin deferral threshold; absence of guidelines for the screening of hemoglobinopathies AS/AC, present in 8% of the target population); specific indications for transfusion, such as platelet use in dengue fever or RBC transfusion in sickle cell disease. Due to the high polymorphism of erythrocyte antigens in Afro-Caribbeans, intra-ethnic transfusion facilitates compatibility for common antigens, but is responsible for the emergence of allo-antibodies difficult to identify in the absence of specific antisera or panels; molecular typing of erythrocyte antigens would allow detection of those patients at risk for immunization, expressing variant antigens or lacking high frequency antigens, as well as the characterization of RBC expressing immunogenic so called low frequency antigens. In an era of periodic emergence of new viruses in Europe (dengue, Chikungunya, West Nile virus...) and with the spreading of diseases with high transfusional requirements, such as sickle cell disease, ultra-marine services represent laboratories for the study of future trends and problems in transfusion medicine.
Assuntos
Doadores de Sangue , Transfusão de Sangue , Infecções por Alphavirus/epidemiologia , Infecções por Alphavirus/prevenção & controle , Infecções por Alphavirus/transmissão , Anemia Falciforme/etnologia , Doadores de Sangue/estatística & dados numéricos , Antígenos de Grupos Sanguíneos/genética , Incompatibilidade de Grupos Sanguíneos/etnologia , Incompatibilidade de Grupos Sanguíneos/prevenção & controle , Segurança do Sangue/normas , Transfusão de Sangue/estatística & dados numéricos , Patógenos Transmitidos pelo Sangue , Febre de Chikungunya , Surtos de Doenças , Seleção do Doador , Etnicidade/genética , França , Hemoglobinopatias/etnologia , Hemoglobinopatias/terapia , Humanos , Isoanticorpos/biossíntese , Malária/epidemiologia , Malária/prevenção & controle , Malária/transmissão , Reunião , Fatores Socioeconômicos , Índias OcidentaisRESUMO
The primary purpose of this study was to develop methods to estimate cancer risk among those with sickle-cell disease (SCD) in California. SCD is an inherited disorder of hemoglobin. Increased hematopoietic cell turnover, chronic inflammation, and reduced immune function have led to speculation that cancer risk may be higher in this group. Despite this conjecture, there is a dearth of population-based studies on cancer risk among those with SCD. In this study, we utilized California's Office of Statewide Health Planning and Development (OSHPD) hospital patient discharge (PD) and emergency department utilization (ED) data systems to identify individuals with SCD. Cases coded as ICD-9-CM 282.60, 282.61, 282.62, 282.63, 282.68, 282.69, 282.41, or 282.42 from any of the 25 diagnostic fields were captured, from 1991-2007 from the PD or 2005-2007 from the ED data systems. A case was excluded if the patient's Social Security number was deemed nonsense; SCD was coded as a comorbid condition for a single visit; or the patient's age was less than 2 years. The resulting SCD case cohort was linked to the California Cancer Registry (CCR). Disease prevalence was estimated for 2006 mathematically using a formula consisting of the cohort sum; SCD live births and deaths from 2005-2007. We identified 152,369 SCD-related admissions to California hospitals and/or emergency departments from 1991-2007. Of those, 9,066 admissions were among patients whose SSN was deemed nonsense and 3,047 among children less than 2 years old. Of the remaining patients, 1,370 had only 1 admission with a comorbid SCD diagnostic code. The final cohort consisted of 7,144 persons, which was linked to the CCR, 1988-2007. We found 203 patients with 216 tumors. We estimated the prevalence of SCD in California, for 2006, at 3,633 individuals. This is the first study to use both California OSHPD PD and ED data systems in concert for SCD case finding and to estimate SCD prevalence in California based on healthcare utilization. It is also the first time that a SCD case cohort has been linked to the CCR to ultimately determine cancer risk in this population.
Assuntos
Anemia Falciforme/epidemiologia , Neoplasias/epidemiologia , Sistema de Registros/estatística & dados numéricos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Anemia Falciforme/etnologia , Anemia Falciforme/genética , California , Criança , Pré-Escolar , Estudos de Coortes , Feminino , Genótipo , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Neoplasias/etnologia , Alta do Paciente/estatística & dados numéricos , Prevalência , Grupos Raciais/estatística & dados numéricos , Fatores de Risco , Adulto JovemAssuntos
Anemia Falciforme/etnologia , Negro ou Afro-Americano , Disparidades em Assistência à Saúde/organização & administração , Qualidade da Assistência à Saúde/organização & administração , Anemia Falciforme/diagnóstico , Anemia Falciforme/terapia , Humanos , Guias de Prática Clínica como AssuntoRESUMO
OBJECTIVES: To explore early experiences of sickle cell disorder (SCD) in families with a young affected child, and the way these experiences influence relations within families. To consider ways in which stigma could be counteracted in health and research programmes in sub Saharan Africa. DESIGN: A qualitative study was conducted in a rural area of coastal Kenya including in-depth interviews with 13 families affected by SCD and 12 staff of a local biomedical research progamme. Purposive selection aimed to maximize diversity in socioeconomic and educational status, religion, severity of illness burden and religion amongst families and draw on relevant experience for staffs. Interviews were recorded, transcribed and analysed using the constant comparative method for family interviews and a thematic framework approach for staff data. RESULTS: Low initial recognition of SCD and its cause were associated with lay practices of surveillance within affected families, contributing to stigmatisation that occurred independently of genetic knowledge. Blame was often placed on mothers, including a risk of blame for misaligned paternity. Mothers are often particularly affected by SCD through the loss of independent livelihoods and their limited options in coping with this chronic condition. CONCLUSIONS: Mothers of children with SCD were particularly vulnerable to stigmatisation within families, with underlying structural influences that suggest these findings may apply to other similar settings in Africa, and have relevance for other genetic conditions. The potential, nature and form of stigmatisation point to the role of effective communication and SCD management in addressing for blame and discriminative effects of having a child with SCD. The findings highlight the importance of broader social programmes targeting underlying gender and economic inequalities.
Assuntos
Anemia Falciforme/etnologia , Relações Familiares/etnologia , Pai/psicologia , Mães/psicologia , Pesquisadores , Estigma Social , Adulto , Idoso , Anemia Falciforme/psicologia , Cultura , Feminino , Política de Saúde , Humanos , Entrevistas como Assunto , Quênia , Masculino , Pessoa de Meia-Idade , População Rural , Bode Expiatório , Fatores Sexuais , Adulto JovemRESUMO
OBJECTIVES: To assess the effectiveness, cost-effectiveness, acceptability and feasibility of offering universal antenatal sickle cell and thalassaemia (SCT) screening in primary care when pregnancy is first confirmed and to model the cost-effectiveness of early screening in primary care versus standard care. DESIGN: A population-based cohort study, cluster randomised trial and refinement of a published decision model. SETTING: Twenty-five general practices from two UK primary care trusts (PCTs) in two inner city boroughs with a high proportion of residents from minority ethnic groups. PARTICIPANTS: Practices were considered eligible if they agreed to be randomised and they were able to provide anonymous data on all eligible pregnant women. Participants were at least 18 years old and consented to take part in the evaluation. INTERVENTIONS: Practices were allocated to intervention, using minimisation and stratifying for PCT and number of partners at the practice, as follows: screening in primary care with parallel father testing (test offered to mother and father simultaneously; n = 8 clusters, 1010 participants); screening in primary care with sequential father testing (test offered to father only if mother identified as carrier; n = 9 clusters, 792 participants); and screening in secondary care with sequential father testing (standard care; n = 8 clusters, 619 participants). MAIN OUTCOME MEASURES: Data on gestational age at pregnancy confirmation and screening date were collected from trial practices for 6 months before randomisation in the cohort phase. The primary outcome measure was timing of SCT screening, measured as the proportion of women screened before 70 days' (10 weeks') gestation. Other outcomes included: offer of screening, rates of informed choice and proportion of women who knew the carrier status of their baby's father by 77 days (11 weeks). RESULTS: For 1441 eligible women in the cohort phase, the median [interquartile range (IQR)] gestational age at pregnancy confirmation was 7.6 weeks (6.0 to 10.7 weeks) and 74% presented in primary care before 10 weeks. The median gestational age at screening was 15.3 weeks (IQR 12.6 to 18.0 weeks). Only 4.4% were screened before 10 weeks. The median delay between pregnancy confirmation and screening was 6.9 weeks (4.7 to 9.3 weeks). In the intervention phase, 1708 pregnancies from 25 practices were assessed for the primary outcome measure. Completed questionnaires were obtained from 464 women who met eligibility criteria for the main analysis. The proportion of women screened by 10 weeks (70 days) was 9/441 (2%) in standard care, compared with 161/677 (24%) in primary care with parallel testing, and 167/590 (28%) in primary care with sequential testing. The proportion of women offered screening by 10 weeks (70 days) was 3/90 (3%) in standard care (note offer of test ascertained for questionnaire respondents only), compared with 321/677 (47%) in primary care with parallel testing, and 281/590 (48%) in primary care with sequential testing. The proportion of women screened by 26 weeks (182 days) was similar across the three groups: 324/441 (73%) in standard care, 571/677 (84%, 0.09) in primary care with parallel testing, and 481/590 (82%, 0.148) in primary care with sequential testing. The screening uptake of fathers was 51/677 (8%) in primary care with parallel testing, and 16/590 (3%) in primary care with sequential testing, and 13/441 (3%) in standard care. The predicted average total cost per pregnancy of offering antenatal SCT screening was estimated to be 13 pounds in standard care, 18.50 pounds in primary care with parallel testing, and 16.40 pounds in primary care with sequential testing. The incremental cost-effectiveness ratio (ICER) was 23 pounds in primary care with parallel testing and 12 pounds in primary care with sequential testing when compared with standard care. Women offered testing in primary care were as likely to make an informed choice as those offered screening by midwives later in pregnancy, but less than one-third of women overall made an informed choice about screening. CONCLUSIONS: Offering antenatal SCT screening as part of pregnancy-confirmation consultations significantly increased the proportion of women screened before 10 weeks (70 days), from 2% in standard care to between 16% and 27% in primary care, but additional resources may be required to implement this. There was no evidence to support offering fathers screening at the same time as women. TRIAL REGISTRATION: Current Controlled Trials ISRCTN00677850.
Assuntos
Anemia Falciforme/diagnóstico , Triagem de Portadores Genéticos/métodos , Testes Genéticos/organização & administração , Cuidado Pré-Natal/organização & administração , Talassemia/diagnóstico , Anemia Falciforme/etnologia , Anemia Falciforme/genética , Análise por Conglomerados , Estudos de Coortes , Análise Custo-Benefício , Técnicas de Apoio para a Decisão , Estudos de Viabilidade , Feminino , Idade Gestacional , Humanos , Consentimento Livre e Esclarecido , Masculino , Pais/psicologia , Aceitação pelo Paciente de Cuidados de Saúde/etnologia , Aceitação pelo Paciente de Cuidados de Saúde/estatística & dados numéricos , Gravidez , Primeiro Trimestre da Gravidez , Análise de Sobrevida , Talassemia/etnologia , Talassemia/genética , Reino Unido/epidemiologiaRESUMO
BACKGROUND: The number of individuals with sickle cell disease (SCD) in the U.S. is unknown. Determination of burden of disease, healthcare issues, and policies is best served by representative estimations of the SCD population. PURPOSE: To update SCD population estimates by using recent U.S. Census and birth-cohort SCD prevalence for at-risk populations as available through the centralized reporting of universal newborn screening for hemoglobinopathies, with an effort to demonstrate the potential effect of early mortality. METHODS: National and state SCD populations were estimated based on the 2008 U.S. Census, using total, African-American, and Hispanic birth-cohort disease prevalence derived from the National Newborn Screening Information System. Estimates were corrected for early mortality for sickle cell anemia using data from the CDC's Compressed Mortality Report and published patient-cohort survival information. RESULTS: National SCD population estimates ranged from 104,000 to 138,900, based on birth-cohort disease prevalence, but from 72,000 to 98,000 when corrected for early mortality. Several limitations were noted in the available data, particularly for SCD mortality in adults. CONCLUSIONS: The number of individuals with SCD in the U.S. may approach 100,000, even when accounting for the effect of early mortality on estimations. A paucity of high-quality data limits appropriate estimation. State-to-state variability may preclude application of state-specific information to other states or to the nation as a whole. Standardized collection and centralized reporting, a surveillance system, will be necessary to assess the size and composition of the U.S. SCD population.
Assuntos
Anemia Falciforme/diagnóstico , Anemia Falciforme/mortalidade , Censos , Triagem Neonatal , Vigilância da População , Adulto , Negro ou Afro-Americano/estatística & dados numéricos , Fatores Etários , Anemia Falciforme/etnologia , Centers for Disease Control and Prevention, U.S. , Estudos de Coortes , Efeitos Psicossociais da Doença , Hispânico ou Latino/estatística & dados numéricos , Humanos , Recém-Nascido , Mortalidade/tendências , Triagem Neonatal/métodos , Vigilância da População/métodos , Prevalência , Fatores Sexuais , Estados Unidos/epidemiologiaRESUMO
This qualitative study used the long interview method with Canadian mothers of African and Caribbean descent to understand the underresearched experience of raising a child with sickle cell disease (SCD). Mothers' realities were explored through three levels of social organization: daily caregiver coping (micro level); community views of SCD, such as stigma (meso level); and systemic SCD health care provision (macro level). Through the use of population health and structural social work perspectives, mothers' experiences were examined in the context of perceived gender and racial oppression. Saturation was achieved after initial interviews with 10 participants and a four-month postinterview with half of the participants. Mothers commonly reported several daily coping challenges: fear of their children's death, separation anxiety, loss of control over life, helplessness, and loneliness/isolation. SCD stigma interacted with racism, contributed to social isolation, and prevented families from organizing as a group. All mothers perceived racism as a salient factor behind inadequate mainstream SCD health care. Recommendations to improve SCD health care and implications for social work practice and research are discussed. This is the first known Canadian psychosocial study of SCD and investigation into SCD stigma outside of rural Nigeria.